Artificial intelligence and neural networks make it possible to expand previous radiological reporting by a decisive factor – objective measurability, also called quantitative radiology.
Thanks to this new technology, pathological deviations in brain volume can be detected much earlier and more precisely than is possible with conventional visual reporting.
AIRAscore software solutions support your specialists in the fields of radiology, neurology and psychiatry in the preparation of findings. For more diagnostic certainty, earlier detection, individual therapies and better medicine in the future.
An excerpt of our references
‘Especially in the case of rare neurological diseases, we are often faced with the problem of whether an individual brain scan is already conspicuous or not. AIRAscore provides great help in our daily work.’
Prof. Dr. Ludger Schöls
Neurologist, University Hospital of Tübingen, Germany
‘With AIRAscore structure, I can support my diagnosis and diagnose changes in brain volume that I would only have been able to detect much later with a purely visual assessment. This added value pleases my patients, but also me as a doctor.’
Dr. Sören Danz
Radiologist, Sindelfingen, Germany
‘I am pleased to be able to offer my patients the additional service provided by AIRAscore. Experience shows that very many patients are afraid of dementia in old age. AIRAscore helps me to distinguish healthy from sick aging and I recognize much earlier than with the pure visual findings whether and when concrete action is needed.’
Dr. Nicola Meyer
Radiologist, Hamburg, Germany
‘I am pleased that with AIRAscore structure we now have a way to benefit from the latest scientific findings in our private practice. It only takes a few minutes until I have exact measurement values directly in my PACS, which significantly improve my reporting options.’
PD Dr. Hansjörg Rempp
Radiologist, Stuttgart, Germany
‘We now use AIRAscore structure routinely with our inpatients. The findings report gives us the necessary security here in the assessment of dementia-related diseases.’
Prof. Dr. Gerhard Eschweiler
Psychiatrist, University Hospital of Tübingen, Germany